相关实验视频

Updated: Jan 12, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

手术后NSCLC的临床结果和预测因素:RAC-TAC研究的发现

Alessio Bruni¹, Davide Franceschini², Beatrice Marini²

¹Radiotherapy Unit, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.

Clinical lung cancer

|November 1, 2025

概括

患有PN2疾病的非小细胞肺癌 (NSCLC) 的术后放射治疗 (PORT) 表明淋巴结解剖程度和阳性结核数量显著影响复发. 远程转移是主要的复发类型,这表明需要综合疗法.

科学领域:

在瘤学瘤学.
辐射瘤学辐射瘤学
胸部外科手术胸部外科手术

背景情况:

最近的试验 (LUNG-ART,PORT-C) 更新了对PN2非小细胞肺癌 (NSCLC) 的术后放射治疗 (PORT) 协议.
评估当代PORT技术的毒性和预后因素对于优化患者结果至关重要.
多中心研究对于稳健评估NSCLC治疗中的临床变量至关重要.

研究的目的:

评估现代PORT技术在pN2 NSCLC中的急性和长期毒性.
确定影响局部控制,远程控制和PORT后整体存活率的临床因素.
为接受PORT的pN2 NSCLC患者开发一个风险分层系统.

主要方法:

一项多中心观察研究,涉及2015-2020年6个意大利中心.
对接受PORT.治疗的NSCLC患者的临床数据的分析.
临床变量与局部复发,远程复发和生存结果的相关性.

主要成果:

局部复发与淋巴结数和患者年龄有关.
远程复发与阳性淋巴结数量和T阶段相关.
总体存活率与阳性淋巴结数量和ECOG性能状态有关,风险分层系统显示了显著的生存差异.

结论:

远程转移是PORT后PN2NSCLC中主要的复发模式.
淋巴结解剖的程度和阳性节点的数量是复发的关键决定因素.
整合全身和局部疗法可能会改善pN2 NSCLC患者的治疗结果.

关键词:

生物标志物生物标志物非小细胞肺癌的肺癌.港口港口港口在手术后进行放射治疗.精准医学是一门精准的医学.辐射疗法辐射疗法

更多相关视频

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...